There are at least two ASX shares that could be worth thinking about this weekend.
The post 2 ASX shares that could be worth looking at this weekend appeared first on The Motley Fool Australia. –
The weekend could be a good time to consider looking into some ASX shares.
Shares are often described as volatile. But that also means that investors are presented with different opportunities at different (sometimes lower) prices.
These two ASX shares might be two worthy of considering:
VanEck Vectors Video Gaming and eSports ETF (ASX: ESPO)
As the name suggests, this investment is an exchange-traded fund (ETF) that aims to give investors exposure to the video gaming and e-sports sector.
There are only a total of 26 businesses in the portfolio. The largest ten positions make up almost 62% of the portfolio. Those names are: Nvidia, Advanced Micro Devices, Tencent, Sea, Nintendo, Activision Blizzard, Netease, Bilibili, Unity Software and Roblox.
This ETF actually has more of the portfolio allocated to Asia than any other region. Asian weightings include China (19.5%), Japan (18%), Singapore (6.7%), South Korea (4.6%) and Taiwan (1.7%). The US has a weighting of 43.2%, so it still has the largest single country weighting. Other countries include Sweden and France.
Two of the selling points of the ETF, according to VanEck, is that it’s a dynamic growth opportunity and it provides technology diversification. The ASX share invests in the future of sports and accesses companies that are positioned to benefit from the increasing popularity of video games and eSports. Its portfolio gives technology diversification away from the usual names like Apple, Amazon, Facebook, Alphabet/Google and Microsoft.
Past performance is not an indicator of future performance. Over the last three years, the index that VanEck Vectors Video Gaming and eSports ETF tracks has produced an average return per annum of 31%.
Volpara Health Technologies Ltd (ASX: VHT)
Volpara is a leading medical technology ASX share.
Its main focus is providing software to help analyse breast scans. The company has been investing (and acquiring businesses) to ensure its breast health platform has the best patient experience, easier integration of expanded patient pathways and provides support for customer reporting compliance, whilst also positioning the company for scale.
A particular focus of the business is ‘risk’ for the patient. It recently bought CRA Health to expand its best-in-class personalised risk offerings to all customers whilst also getting a better connection with genetics companies.
The company is seeing a rising gross profit margin, an increasing group average revenue per user (ARPU) and improving scalability.
In FY21, the gross profit margin increased to 91%. The group ARPU increased from US$1.16 at the FY21 half-year result to US$1.40 in the FY21 result. In FY21, total revenue increased 57% and gross profit went up 67%, whilst operating costs only increased by 8%.
In FY22, the ASX share is expecting higher ARPU, new customers, upselling existing customers, acquisitions and a high retention rate.
Most new sales are now for two or three of Volpara’s products, representing significantly increased ARPU and the relationship with genetics companies is expected to increase that further.
The post 2 ASX shares that could be worth looking at this weekend appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
*Returns as of May 24th 2021
Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia has recommended VanEck Vectors ETF Trust – VanEck Vectors Video Gaming and eSports ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.